Document text
Principal Investigator: Viviana A Simon
Organization: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Fiscal Year: 2022
Award: $283,217
Funding agency: National Institute of Allergy and Infectious Diseases
SUMMARY
The VIVA Clinical Core B provides the infrastructures needs to support standardized approaches for
the recruitment, longitudinal retention and clinical characterization of human subjects enrolled in
observational studies. The Core B will facilitate patient centered research through activities and
services such as access to populations of people who a) were infected with SARS-CoV-2, influenza
virus or dengue virus, b) received immunization(s) for SARS-CoV-2, influenza virus and dengue virus.
Participant derived biological specimen and corresponding clinical information will be collected in
domestic as well as international settings. The Core B will continue with longitudinal follow-up of the
enrolled participants, lead recruitment of new participants with acute infections by viral pathogens of
interest. It will direct the biospecimen collection, banking at the Icahn School of Medicine at Mount Sinai
(ISMMS) and will ensure timely sample distribution to the three different Projects and the two other data
producing Cores (Immune Phenotyping Core C and Genomics Core D) within the VIVA HIPC. Aim
1 will focus on specimens from SARS-CoV-2 studies conducted in the Mount Sinai Health System
(MSHS) in NY, USA as well as from studies conducted in Buenos Aires, Argentina for Project 1. Aim
2 will focus on specimens from influenza studies conducted at the MSHS in NY, USA as well as from
studies conducted in Buenos Aires, Argentina for Project 2. Aim 3 will focus on specimens from
completed dengue vaccine and challenge clinical trials conducted at Johns Hopkins Bloomberg School
of Public Health, MD, USA for Project 3. Aim 4 will source de-identified tonsil tissues from the Mount
Sinai Hospital Biorepository in the Department of Pathology at ISMMS, NY, USA, for Project 1, Project
2 and Project 3. Aim 5 will ensure harmonization of the biological specimen collection time points and
banking modalities across the different study protocols. It will support the Data Management and
Analysis Core E by ensuring high quality clinical datasets are generated through implementing error-
prevention strategies in the data collection across all the studies supported by Core B. Lastly, the
Clinical Core will also provide regulatory support and implement appropriate human subject protection
measures.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><Active Follow-up><Ad vector><Adenoviral Vector><Adenovirus Vector><Argentina><Biological><Biological Specimen Banks><Biological Substance Banks><Blood Plasma><Blood Serum><Body Tissues><Breakbone Fever Virus><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infection><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 vaccination><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 infection><COVID19 pandemic><COVID19 public health crisis><COVID19 vaccination><COVID19 vaccine><COVID19 virus><CV-19><CV19><Clinical><Clinical Protocols><Clinical Research><Clinical Study><CoV-2><CoV2><Collection><Communicable Diseases><Conduct Clinical Trials><Cryofixation><Cryopreservation><DENV vaccine><Data><Data Analyses><Data Analysis><Data Collection><Data Set><Dataset><Dengue Vaccine><Dengue Virus><Dengue fever virus><Dengue virus vaccine><Enrollment><Ensure><Flu vaccination><Genomics><Grippe><Health system><Hospitals><Human><Immune><Immune response><Immunes><Immunity><Immunization><Immunization Programs><Immunologic Sensitization><Immunologic Stimulation><Immunological Sensitization><Immunological Stimulation><Immunological response><Immunology><Immunostimulation><Individual><Infection><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Influenza Vaccines><Influenza Virus><Influenza immunization><Influenza vaccination><Infrastructure><International><Investigators><Lead><Measures><Medical><Messenger RNA><Mission><Modality><Modern Man><New York City><Observation research><Observation study><Observational Study><Observational research><Operations Research><PBMC><Participant><Pathology><Patients><Pb element><Peripheral Blood Mononuclear Cell><Persons><Phenotype><Plasma><Plasma Serum><Population><Preventative strategy><Prevention strategy><Preventive strategy><Prophylactic vaccination against influenza><Protocol><Protocols documentation><Public Health Schools><Research><Research Personnel><Research Specimen><Researchers><Reticuloendothelial System, Serum, Plasma><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV-2 vaccination><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 epidemic><SARS-CoV2 infection><SARS-CoV2 pandemic><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Serum><Services><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccination><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Source><Specimen><Standardization><Time><Tissues><Tonsil><Tonsillectomy><Vaccination><Vaccination Programs><Viral><Wuhan coronavirus><active followup><acute infection><adeno vector><adenovector><base><biobank><biologic><biological specimen repository><biorepository><biosample repository><biospecimen bank><biospecimen repository><cold preservation><cold storage><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccination><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus infectious disease-19><data interpretation><data management><enroll><flu immunisation><flu vaccine><flu virus vaccine><follow up><follow-up><followed up><followup><hCoV19><healthy volunteer><heavy metal Pb><heavy metal lead><host response><human pathogen><human subject><human subject protection><immune system response><immunoresponse><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><influenza virus vaccination><influenza virus vaccine><influenzavirus><interest><mRNA><medical college><medical schools><nCoV2><pathogenic virus><patient centered><patient oriented><recruit><sample collection><school of medicine><seasonal flu><seasonal influenza><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><specimen bank><specimen collection><specimen repository><tonsillar><vaccinate against COVID-19><vaccinate against COVID19><vaccinate against SARS-CoV-2><vaccinate against coronavirus disease 2019><vaccinate against severe acute respiratory syndrome coronavirus 2><vaccination against COVID-19><vaccination against COVID19><vaccination against SARS-CoV-2><vaccination against Severe acute respiratory syndrome coronavirus 2><vaccination against coronavirus disease 2019><vaccination against influenza><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine against flu><vaccine against influenza><vaccine for novel coronavirus><viral pathogen><virology><virus pathogen>